MMA
RMD icon

Miracle Mile Advisors’s ResMed RMD Stock Holding History

Miracle Mile Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,110
Closed -$249K – 1027
2026
Q1 		$249K Sell
1,110
-32
-3% -$7.97K ﹤0.01% 784
2025
Q4 		$275K Sell
1,142
-8
-0.7% -$2.05K ﹤0.01% 739
2025
Q3 		$315K Buy
1,150
+54
+5% +$14.8K ﹤0.01% 670
2025
Q2 		$283K Buy
1,096
+173
+19% +$41.3K ﹤0.01% 598
2025
Q1 		$207K Buy
923
+6
+0.7% +$1.4K ﹤0.01% 605
2024
Q4 		$210K Buy
917
+77
+9% +$18.5K ﹤0.01% 595
2024
Q3 		$205K Buy
+840
New +$188K ﹤0.01% 493
2024
Q1 		– Sell
-1,600
Closed -$275K – 519
2023
Q4 		$275K Buy
+1,600
New +$246K 0.01% 408

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Miracle Mile Advisors's RMD Position: Q2 2026 in Review

Miracle Mile Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,110 shares — an estimated $249K sold.

Miracle Mile Advisors first reported a position in RMD in Q4 2023 and held it in 8 quarters. The position peaked at $315K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Miracle Mile Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Miracle Mile Advisors sold 1,110 ResMed shares in Q2 2026, an estimated $249K.
  • Miracle Mile Advisors first reported a position in ResMed in Q4 2023 and held it in 8 quarters.
  • Miracle Mile Advisors's ResMed position peaked at $315K in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.